NeuroAid was historically developed in China as a traditional Chinese medicine to help stroke patients achieve better rehabilitation. After 5 years, it is now reaching about 200,000 patients every year there.
Moleac, a bio pharmacy company, is bringing NeuroAid to western medicine internationally and ensures it meets western medicine standards to attend to the needs of stroke sufferers: NeuroAid supports them to achieve better neurological and functional recovery.
NeuroAid is to be taken by stroke patients after the stroke for better recovery of motor and cognitive functions.